Understand the source comparison
Best Peptides for Vocal Cord Healing: Evidence Comparison
| Peptide | Primary Mechanism | Tissue Specificity | Typical Dosing | Fibrosis Reduction (vs Control) | Time to Measurable Effect | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF upregulation, NO pathway activation, FAK-paxillin signaling for collagen
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Peptide | Primary Mechanism | Tissue Specificity | Typical Dosing | Fibrosis Reduction (vs Control) | Time to Measurable Effect | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF upregulation, NO pathway activation, FAK-paxillin signaling for collagen organization | High affinity for mucosal tissue, stable in acidic/enzymatic environments | 200–500 mcg daily, subcutaneous or oral | 40–60% reduction in Type III collagen deposition (animal models) | 48–72 hours for vascular changes, 2–3 weeks for structural remodeling | Gold standard for mucosal repair. Unique stability and selectivity for organized collagen deposition || TB-500 | G-actin binding (increased cell migration), downregulation of IL-6 and TNF-alpha | Broad connective tissue affinity, particularly effective in chronic inflammation | 2–5 mg twice weekly (loading), 2 mg weekly (maintenance) | 30–45% reduction in inflammatory markers, indirect fibrosis reduction via cytokine modulation | 1–2 weeks for anti-inflammatory ef